Integrative Multi-Omics and Network Analyses Reveal Pathogenic and Protective Pathways in Centronuclear Myopathies
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262311572 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Alix Simon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), CNRS UMR 7104, INSERM UMRS 1258, Université de Strasbourg, 67404 Illkirch, Fr…. Hauptthemen laut MEDLINE: Myopathies, Structural, Congenital, Gene Regulatory Networks. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Association Francaise contre les Myopathies, Muscular Dystrophy Association, Ecole Inserm Pfizer Innovation.
Abstract (Originalsprache)
Centronuclear and myotubular myopathies (CNMs) are rare, inherited muscle disorders characterized by muscle atrophy, weakness, and altered muscle fiber structure, primarily caused by mutations in MTM1, DNM2, or BIN1. The molecular mechanisms driving CNM are only partially understood, and no curative therapies are available. To elucidate molecular pathways involved in CNMs, we present an integrative multi-omics analysis across several CNM mouse models untreated or treated with pre-clinical strategies, combining transcriptomic, proteomic, and metabolomic datasets with curated interaction, metabolic, tissue, and phenotype knowledge using network-based approaches. Weighted Gene Co-expression Network Analysis (WGCNA) identified gene modules commonly altered in three CNM genetic forms. Modules correlated with improved muscle function were enriched for processes such as muscle contraction, RNA metabolism, and oxidative phosphorylation, whereas modules linked to disease severity were enriched for immune response, innervation, vascularization, and fatty acid oxidation. We further integrated transcriptomic, proteomic, and metabolomic data from the Mtm1−/y mouse model with public knowledge bases into a multilayer network, and explored it using a random walk with restart approach. These analyses highlighted metabolites closely connected to CNM phenotypes, some of which may represent candidates for nutritional or pharmacological modulation. Our findings illustrate how integrative multi-omics and network analyses reveal both pathogenic and protective pathways in CNM and provide a foundation for identifying novel therapeutic opportunities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), CNRS UMR 7104, INSERM UMRS 1258, Université de Strasbourg, 67404 Illkirch, France.
- Complex Systems and Translational Bioinformatics (CSTB), ICube Laboratory-CNRS, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, 67000 Strasbourg, France.
ORCID-Profile: Alix Simon, Julie D Thompson, Jocelyn Laporte
Förderung
- Association Francaise contre les Myopathies
- Muscular Dystrophy Association
- Ecole Inserm Pfizer Innovation
- Société Française de Myologie
- IdEx Unistra
- SFRI-STRAT'US
- EUR IMCBio
- SFRI-STRAT’US
Zitieren
APA
Simon, A., Gineste, C., Reiss, D., Thompson, J. D., & Laporte, J. (2025). Integrative Multi-Omics and Network Analyses Reveal Pathogenic and Protective Pathways in Centronuclear Myopathies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311572
Vancouver
Simon A, Gineste C, Reiss D, Thompson JD, Laporte J. Integrative Multi-Omics and Network Analyses Reveal Pathogenic and Protective Pathways in Centronuclear Myopathies. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311572
BibTeX
@article{Simon2025,
author = {Simon, Alix and Gineste, Charlotte and Reiss, David and Thompson, Julie D and Laporte, Jocelyn},
title = {Integrative Multi-Omics and Network Analyses Reveal Pathogenic and Protective Pathways in Centronuclear Myopathies},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262311572}
}
EUVIMED